These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 24822232)
1. Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye. Mikhail M; Sallam A Med Hypothesis Discov Innov Ophthalmol; 2013; 2(4):113-20. PubMed ID: 24822232 [TBL] [Abstract][Full Text] [Related]
2. Review and update of intraocular therapy in noninfectious uveitis. Sallam A; Taylor SR; Lightman S Curr Opin Ophthalmol; 2011 Nov; 22(6):517-22. PubMed ID: 21897242 [TBL] [Abstract][Full Text] [Related]
3. Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN Bodaghi B; Nguyen QD; Jaffe G; Khoramnia R; Pavesio C J Ophthalmic Inflamm Infect; 2020 Nov; 10(1):32. PubMed ID: 33251553 [TBL] [Abstract][Full Text] [Related]
4. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. Arcinue CA; Cerón OM; Foster CS J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752 [TBL] [Abstract][Full Text] [Related]
5. New developments in corticosteroid therapy for uveitis. Taylor SR; Isa H; Joshi L; Lightman S Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis. Park JG; Callaway NF; Ludwig CA; Mahajan VB Am J Ophthalmol Case Rep; 2020 Sep; 19():100859. PubMed ID: 32793845 [TBL] [Abstract][Full Text] [Related]
12. Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial. Couret C; Poinas A; Volteau C; Riche VP; Le Lez ML; Errera MH; Creuzot-Garcher C; Baillif S; Kodjikian L; Ivan C; Le Jumeau de Kergaradec LM; Chiffoleau A; Jobert A; Jaulin J; Biron L; Hervouet E; Weber M Trials; 2020 Feb; 21(1):159. PubMed ID: 32041669 [TBL] [Abstract][Full Text] [Related]
13. Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation. Sadiq MA; Agarwal A; Soliman MK; Hanout M; Sarwar S; Do DV; Nguyen QD Expert Opin Drug Saf; 2015 Jul; 14(7):1147-56. PubMed ID: 25994877 [TBL] [Abstract][Full Text] [Related]
15. New Drugs and New Posterior Delivery Methods in CME. de Oliveira Dias JR; Nunes RP; Goldhardt R Curr Ophthalmol Rep; 2017 Jun; 5(2):160-168. PubMed ID: 29062594 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable intraocular therapies for retinal disorders: progress to date. Kuno N; Fujii S Drugs Aging; 2010 Feb; 27(2):117-34. PubMed ID: 20104938 [TBL] [Abstract][Full Text] [Related]